These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22788525)

  • 1. A phase II, single-blind, randomized, crossover evaluation of the safety and efficacy of avanafil using visual sexual stimulation in patients with mild to moderate erectile dysfunction.
    Hellstrom WJ; Freier MT; Serefoglu EC; Lewis RW; DiDonato K; Peterson CA
    BJU Int; 2013 Jan; 111(1):137-47. PubMed ID: 22788525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of avanafil for treating erectile dysfunction: results of a multicentre, randomized, double-blind, placebo-controlled trial.
    Zhao C; Kim SW; Yang DY; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Moon KH; Chung WS; Min KS; Suh JK; Hyun JS; Park K; Park JK
    BJU Int; 2012 Dec; 110(11):1801-6. PubMed ID: 22448738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Study.
    Hellstrom WJ; Kaminetsky J; Belkoff LH; Goldstein I; Tursi JP; Uy J; Peterson CA; Bowden CH; Day WW
    J Urol; 2015 Aug; 194(2):485-92. PubMed ID: 25591992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy.
    Mulhall JP; Burnett AL; Wang R; McVary KT; Moul JW; Bowden CH; DiDonato K; Shih W; Day WW
    J Urol; 2013 Jun; 189(6):2229-36. PubMed ID: 23219537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhao C; Kim SW; Yang DY; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Min KS; Park K; Park JK
    Eur Urol; 2011 Aug; 60(2):380-7. PubMed ID: 21458153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.
    Hatzichristou DG; Aliotta P; Auerbach S; Barkin J; Lording D; Murdock M; Wilkins HJ; McBride TA; Colopy MW; Carson CC;
    Clin Ther; 2005 Sep; 27(9):1452-61. PubMed ID: 16291418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction.
    Goldstein I; McCullough AR; Jones LA; Hellstrom WJ; Bowden CH; Didonato K; Trask B; Day WW
    J Sex Med; 2012 Apr; 9(4):1122-33. PubMed ID: 22248153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men.
    Price DE; Gingell JC; Gepi-Attee S; Wareham K; Yates P; Boolell M
    Diabet Med; 1998 Oct; 15(10):821-5. PubMed ID: 9796881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label, long-term evaluation of the safety, efficacy and tolerability of avanafil in male patients with mild to severe erectile dysfunction.
    Belkoff LH; McCullough A; Goldstein I; Jones L; Bowden CH; DiDonato K; Trask B; Day WW
    Int J Clin Pract; 2013 Apr; 67(4):333-41. PubMed ID: 23521325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: a single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers.
    Jung J; Choi S; Cho SH; Ghim JL; Hwang A; Kim U; Kim BS; Koguchi A; Miyoshi S; Okabe H; Bae KS; Lim HS
    Clin Ther; 2010 Jun; 32(6):1178-87. PubMed ID: 20637970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of oral sildenafil in Thai men with erectile dysfunction: a randomized, double-blind, placebo controlled, flexible-dose study.
    Kongkanand A; Ratana-Olarn K; Ruangdilokrat S; Tantiwong A;
    J Med Assoc Thai; 2003 Mar; 86(3):195-205. PubMed ID: 12757058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction.
    Diamond LE; Earle DC; Rosen RC; Willett MS; Molinoff PB
    Int J Impot Res; 2004 Feb; 16(1):51-9. PubMed ID: 14963471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
    Blonde L
    Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Therapeutic Confirmatory Study to Evaluate the Safety and Efficacy of Avanafil in Korean Patients with Erectile Dysfunction.
    Park HJ; Kim SW; Kim JJ; Lee SW; Paick JS; Ahn TY; Park K; Park JK; Park NC
    J Korean Med Sci; 2017 Jun; 32(6):1016-1023. PubMed ID: 28480661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction.
    Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F
    Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASSESS-3: a randomised, double-blind, flexible-dose clinical trial of the efficacy and safety of oral sildenafil in the treatment of men with erectile dysfunction in Taiwan.
    Chen KK; Hsieh JT; Huang ST; Jiaan DB; Lin JS; Wang CJ;
    Int J Impot Res; 2001 Aug; 13(4):221-9. PubMed ID: 11494079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
    Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of sildenafil citrate in treating erectile dysfunction in patients with combat-related post-traumatic stress disorder: a double-blind, randomized and placebo-controlled study.
    Safarinejad MR; Kolahi AA; Ghaedi G
    BJU Int; 2009 Aug; 104(3):376-83. PubMed ID: 19389004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, tolerability and satisfaction with sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction.
    Buvat J; Hatzichristou D; Maggi M; Farmer I; Martínez-Jabaloyas JM; Miller PJ; Schnetzler G
    BJU Int; 2008 Dec; 102(11):1645-50. PubMed ID: 18710446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.